Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
November 06, 2024 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
Memo Therapeutics AG Appoints Frits van Alphen, MD as Chief Development Officer
November 04, 2024 07:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Frits is an industry veteran with a proven track record in nephrology drug development, including the successful development of Velphoro® and Ferinject® at Vifor Pharma Schlieren /...
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
October 29, 2024 07:46 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
The American Kidney Fund Launches ‘Answers Unlocked’ Educational Campaign to Help Kidney Patients Learn About the Benefits of Genetic Testing
October 22, 2024 12:17 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) launched its newest educational campaign, “Answers Unlocked,” to spread awareness of the need and benefits of...
Renown Health Welcomes First Kidney Transplant Surgeon & Chief of Transplant Surgery Program
October 10, 2024 14:42 ET
|
Renown Health
Reno, NEV., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Renown Health announces the appointment of Ernesto P. Molmenti, M.D., PH.D. M.B.A. as the hospital’s inaugural kidney transplant surgeon, Chief of...
On the Heels of Historic Hurricane Helene, American Kidney Fund Activates Disaster Relief Program to Support Dialysis and Post-Transplant Patients Affected by Hurricane Milton
October 10, 2024 13:07 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 10, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has turned on its Disaster Relief Program to aid dialysis and post-transplant patients living in areas impacted by...
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
October 08, 2024 08:30 ET
|
OncoCyte Corporation
Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO...
Renown Welcomes the First Transplant Nephrologist to Region & Announces Renown Transplant Institute
October 03, 2024 17:26 ET
|
Renown Health
Reno, NEV., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Renown Health is pleased to announce the appointment of Narisorn Atsava-Svate, MD, a distinguished transplant nephrologist. With over 18 years of...
American Kidney Fund Hosts ‘Dialysis at Home’ Summit to Share Knowledge and Resources about Home Dialysis with the Kidney Community
October 03, 2024 09:12 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) is hosting the third annual Dialysis at Home summit, a free, online event in which participants will hear from...
Corporate and Individual Donations Provide Much-Needed Support to Kidney Patients Impacted by Hurricane Helene Through the American Kidney Fund’s Disaster Relief Program
October 02, 2024 09:48 ET
|
American Kidney Fund
ROCKVILLE, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- In the wake of the devastation of Hurricane Helene across the Southeast, the American Kidney Fund’s (AKF) Disaster Relief Program is continuing to...